Greg Zante - Chief Financial Officer at Viking Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
VKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Greg Zante - trading volume in the past year for Viking Therapeutics, Inc.

Holdings reported by Greg Zante for Viking Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.00001 per share 175K $13.3M $76.07 May 3, 2024 Direct
Common Stock, par value $0.00001 per share 165K $7.16M $43.32 Jan 6, 2025 Direct
Stock Option (Right to Buy) 37.2K Jan 3, 2025 Direct Common Stock

Transactions reported by Greg Zante for Viking Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.